Chair’s Opening Remarks

Time: 9:50 am
day: GENE EDITING INNOVATION discussion day

Speakers:

TJ Cradick
TJ Cradick TJ Cradick is the Chief Scientific Officer (CSO) at Excision BioTherapeutics, a clinical-stage biotech company that is developing CRISPR-based therapies to cure viral infectious diseases Read more